DISPHAR INT B V has a total of 19 patent applications. Its first patent ever was published in 2007. It filed its patents most often in Australia, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals and medical technology are RECKITT BENCKISER HEALTHCARE (UK) LTD, OOO VALENTA INTELLEKT and DISPHAR INT BV.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Canada | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Argentina | 1 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | Hungary | 1 | |
#9 | Russian Federation | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Medical purpose containers |
# | Name | Total Patents |
---|---|---|
#1 | Doshi Hiteshkumar Anilkant | 5 |
#2 | De Fluiter Hendrik Cornelis | 5 |
#3 | Van Tomme Sophie Rolande | 4 |
#4 | De Fluiter Hendrick Cornelis | 2 |
#5 | Rodriguez Calvo Monica | 2 |
#6 | Van Der Meij Paulus Franciscus Cornells | 2 |
#7 | Lukas John | 2 |
#8 | Gonzales Rasielle Joy | 2 |
#9 | Hiteshkumar Anilkant Doshi | 2 |
#10 | Tendulkar Anjali Rajesh | 2 |
Publication | Filing date | Title |
---|---|---|
EP3653214A1 | Improved dosage regimen for ursodeoxycholic acid based on alkaline phosphatase levels in the treatment of chronic cholestatic liver diseases | |
EP3307248A1 | Improved pharmaceutical formulation |